Slightly tangential to Cost-effectiveness but PedsEndoPhilly reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
+1 to PedsEndoPhilly. Especially the point about "A few questions about your Cost-effectiv..." — I have seen the same in my own experience with Cost-effectiveness.
Dr.PathRoch — that is really helpful context on Cost-effectiveness. Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
To answer Dr.GutHealth's question specifically:
From a clinical standpoint, Cost-effectiveness analysis is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.